AVITA Medical, Inc. Stock Other OTC
Equities
AVHHL
AU000000AVH4
Biotechnology & Medical Research
Sales 2024 * | 114M 75.67M | Sales 2025 * | 158M 105M | Capitalization | 340M 226M |
---|---|---|---|---|---|
Net income 2024 * | -67M -44.48M | Net income 2025 * | -35M -23.24M | EV / Sales 2024 * | 2.83 x |
Net cash position 2024 * | 17.14M 11.38M | Net Debt 2025 * | 7.05M 4.68M | EV / Sales 2025 * | 2.19 x |
P/E ratio 2024 * |
-5
x | P/E ratio 2025 * |
-11.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.3% |
Latest transcript on AVITA Medical, Inc.
1st Jan change | Capi. | |
---|---|---|
+26.65% | 49.18B | |
+0.66% | 42.11B | |
+50.35% | 40.37B | |
-5.26% | 28.85B | |
+12.47% | 26.09B | |
-21.91% | 18.71B | |
+8.41% | 13.26B | |
+31.14% | 12.32B | |
-0.20% | 11.99B |